MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bioamber Company Profile (NYSE:BIOA)

Consensus Ratings for Bioamber (NYSE:BIOA) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.63 (288.96% upside)

Analysts' Ratings History for Bioamber (NYSE:BIOA)
Show:
DateFirmActionRatingPrice TargetActions
5/4/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Credit SuisseBoost Price TargetOutperform$15.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016HC WainwrightReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016Rodman & RenshawInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2014BarclaysLower Price TargetOverweight$20.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/18/2014Societe GeneraleBoost Price Target$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/31/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha